Amgen
BLINCYTO
Manufacturer:
Amgen
Name:
BLINCYTO
Category:
J Code
HCPCS:
J9039
NDC(s):
55513-0160-01,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
BLINCYTO is a Cancer drug manufactured by Amgen and administered via the Intravenous route of administration. The J Code: J9039 is aligned to the drug BLINCYTO.